CDI Laboratories, Inc is a biotechnology company located in Mayaguez, Puerto Rico engaged in the development and commercialization of highly specific monoclonal antibodies. CDI’s laboratory facilities are located in the Bioprocess Development and Training Complex, a Commonwealth of Puerto Rico-sponsored research and training facility devoted to the advancement of the field of biotechnology.
CDI offers custom monoclonal antibody production services to researchers, biotechnology and pharmaceutical companies.
CDI is currently validating a high-throughput monoclonal antibody production platform that will serve as a foundation for production of monoclonal antibodies against proprietary antigens. This project is being done with the strategic and economic support of the Puerto Rico Science Technology and Research Trust, a nonprofit organization under the umbrella of the Puerto Rico Industrial Development Corporation, a local Government corporation that fosters the industrial and economic development of Puerto Rico.
